A new technology entitled GeneXpert was deemed a ‘game-changer’ in the world of TB diagnostics. To reduce the burden and mortality of TB, it is imperative to not only have advanced technologies to detect TB bacteria, but to also have experts that know how to use the new technology. In 2016, USAID TB CARE II funded the attendance of 11 people from select low or middle‐income countries to attend the McGill Summer Institute in Infectious Diseases and Global Health to take courses on Advanced TB Diagnostic Research.
TB CARE II supports health systems improvement through our country programs, emphasizing management capacity building,
integration, and results-oriented process improvement.
On October 10-11, 2016, delegates from twenty, primarily low- and middle-income countries gathered at the Council for Scientific and Industrial Research (CSIR) conference center in Pretoria, South Africa.
In 2015, USAID TB CARE II project began an initiative to address TB in miners in the Southern African Region. The overall objective is to improve detection and management of TB and other co-morbidities among the mine workers and their families. This would also help to control the spread of TB and reduce new incidences of TB.
TB CARE II recently hosted a technical meeting on TB infection control in September 2016 in Hanoi, Vietnam.
Toolkits and job aids in Bengali developed by the USAID TB CARE II Bangladesh project are now featured on the USAID K4Health website and are available for download here: https://www.k4health.org/toolkits/bangladesh-mnch/ykssmaa.
TB CARE II is excited to announce that it will be expanding its field support presence into South Africa for FY2015. TB CARE II will build on the activities and approaches utilized by the USAID TB Program South Africa, also implemented by University Research Co., LLC (URC), which from 2009-2014 has supported the National Department of Health (NDOH) in improving early case detection, increasing access to diagnostics, ensuring treatment support for patients on TB treatment and ensuring that there is provision of appropriate and timely HIV care for TB patients and ART treatment for all TB/HIV
In April 2014, TB CARE II, in partnership with the Tajikistan Ministry of Health and Social Protection, established the Macheton National TB Hospital in Tajikistan as an infection control demonstration site. The purpose of this site is to document the magnitude of TB burden caused by poor infection control, establish more effective infection control practices, and to use the site as a training base to build national and regional interest and investment in TB infection control. In attendance at the launch event were USAID Deputy Chief of Mission Robert Burgess, the Deputy Minister of Healt